|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | European evidence based consensus for endoscopy in inflammatory bowel disease显示文摘 | Vito Annese Marco Daperno Matthew D. Rutter Aurelien Amiot Peter Bossuyt James East Marc Ferrante Martin G?tz Konstantinos H. Katsanos Ralf Kie?lich Ingrid Ordás Alessandro Repici Bruno Rosa Shaji Sebastian Torsten Kucharzik Rami Eliakim | 2013 | Journal of Crohn’s and Colitis2013，，12： | 7 |
| 2 | A randomized open-label trial of on-demand rabeprazole vs ranitidine for patients with non-erosive reflux disease显示文摘AIM:To compare the efficacy of the proton-pump inhibitor,rabeprazole,with that of the H 2-receptor antagonist,ranitidine,as on-demand therapy for relieving symptoms associated with non-erosive reflux disease(NERD).METHODS:This is a single center,prospective,randomized,open-label trial of on-demand therapy with rabeprazole(group A) vs ranitidine(group B) for 4 wk.Eighty-three patients who presented to the American University of Beirut Medical Center with persistent gastroesophageal reflux disease(GERD) symptoms and a normal upper gastrointestinal endoscopy were eligible for the study.Patients in group A(n = 44) were allowed a maximum rabeprazole dose of 20 mg twice daily,while those in group B(n = 39) were allowed a maximum ranitidine dose of 300 mg twice daily.Efficacy was assessed by patient evaluation of global symptom relief,scores of the SF-36 quality of life(QoL) questionnaires,total number of pills used,and number of medication-free days.RESULTS:Among the 83 patients who were enrolled in the study,76 patients(40 in the rabeprazole group and 36 in the ranitidine group) completed the 4-wk trial.Baseline characteristics were comparable between both groups.After 4 wk,there was no significant difference in the subjective global symptom relief between the rabeprazole and the ranitidine groups(71.4% vs 65.4%,respectively;P = 0.9).There were no statistically significant differences between mean cumulative scores of the SF-36 QoL questionnaire for the two study groups(rabeprazole 22.40 ± 27.53 vs ranitidine 17.28 ± 37.06;P = 0.582).There was no significant difference in the mean number of pills used(rabeprazole 35.70 ± 29.75 vs ranitidine 32.86 ± 26.98;P = 0.66).There was also no statistically significant difference in the mean number of medication-free days between both groups.CONCLUSION:Rabeprazole has a comparable efficacy compared to ranitidine when given on-demand for the treatment of NERD.Both medications were associated with improved quality of life. | Abdallah A Kobeissy Jana G Hashash Faek R Jamali Assaad M Skoury Reham Haddad Sarah El-Samad Rami Ladki Rola Aswad Assaad M Soweid | 2012 | World Journal of Gastroenterology2012，18，19： | 4 |
| 3 | Presence of thyroid-associated ophthalmopathy in Hashimoto's thyroiditis显示文摘·AIM: To determine the prevalence of ophthalmopathy in Hashimoto's patients and to make a comparison in subgroups of patients·METHODS: The study involved 110 Hashimoto's thyroiditis patients and 50 control subjects attending to the endocrinology department of the hospital. Subgroup classification of patients was made as euthyroid,subclinic and clinic in Hashimato's thyroiditis. All patients were evaluated by a single experienced ophthalmologist for the prevalence and characteristics of eye signs.·RESULTS:Theoverallprevalencesofeyechanges were22.7%(25 patients) in patients and 4%(2 persons) in control subjects respectively(P =0.002). In patients the most common symptom was retrobulbar eye pain with or without any eye movement. Thirteen patients had significant upper eyelid retraction(11.8%). Six patients had eye muscle dysfunction as reduced eye movements in up gaze. In control patients one person had proptosis and another had lid retraction. The clinical activity score and classification of the ophthalmopathy did not show any significant differences among subgroups.·CONCLUSION:Theeyesignsweremostlymild(22.7%)and the most common eye sign was the presence of upper eyelid retraction(11.8%). Additionally six patients had eye muscle dysfunction as reduced eye movements in up gaze. Therefore we recommend to make a routine ophthalmic examination in Hashimoto's thyroiditis patients in order not to omit the associated ophthalmopathy. | Emrah Kan Elif Kilic Kan Gülcin Ecemis Ramis Colak | 2014 | International Journal of Ophthalmology(English edition)2014，7，4： | 2 |
| 4 | Identification and characterization of inland ship plumes over Vancouver, BC显示文摘 | Lu G Brook J R Rami Alfarra M | 2006 | Atmospheric Environment2006，40，15： | 1 |
| 5 | Thermal Stability of Vanadia-titania Catalysts显示文摘 | OLIVERL G RAMIS G BUSCA G | 1993 | J Mater Chem1993，3，12： | 1 |
| 6 | The Reduction of Nickel Dimethylglyoxime Complex Preadsorhed oft Mereu- ry显示文摘 | Rami'rez S Gordillo G J Posadas D | 1997 | Journal of E[ectroanalytical Chemistry1997，431，2： | 1 |
| 7 | Transgenic mouse model of ventricular preexcitation and atrioventricular reentrant tachycardia induced by an AMP-activated protein kinase loss-of-function mutation responsible for Wolff-Parkinson-White syndrome显示文摘 | Sidhu J S Rajawat Y S Rami T G Gollob M H Wang Z Yuan R | 2005 | Circulation2005，111，： | 1 |
| 8 | Chemical and mechanistic aspects of the selective catalytic reduction of NOx by ammonia over oxide catalysts:A review显示文摘 | BUSCA G LIEETI L RAMIS G BERTI F | 1998 | Appl Catal B1998，18，12： | 1 |
| 9 | An FT-IR study of the adsorption and oxidation of N-containing compounds over Fe 2 O 3 /Al 2 O 3 SCR catalysts显示文摘 | Ramis G Angeles Larrubia M | 2004 | Journal of Molecular Catalysis A:Chemical2004，215，12： | 1 |
| 10 | Chemical and mechanistic aspects of the selective catalytic reduction of NO by ammonia over oxide cat- alysts : A review 显示文摘 | Busca G Lietti L Ramis G | 1998 | Applied Catalysis B : Environmental1998，18，12： | 1 |
| 11 | Towards a saturated sorghum map using RFLP and AFLP markers显示文摘 | Boivin K Deu M Rami J F Trouche G and Hamon P | 1999 | Theor Appl Genet1999，98，： | 1 |
| 12 | Catalytic abatement of NQx: Chemical and mechanistic aspects 显示文摘 | BUSCA G LARRUBIA M A ARRIGHI L RAMIS G | 1993 | Catalysis Toda-1993，16，： | 1 |
| 13 | An FT-IR study of the adsorption and oxidation of N-containing compounds over Fe 2 O 3 -TiO 2 SCR catalysts显示文摘 | Larrubia M A Ramis G Busca G | 2001 | Applied Catalysis B:Environmental2001，30，12： | 1 |
| 14 | Chemical and mechanistic aspects of the selective catalytic reduction of NOx by ammonia over oxide catalysts:A review 显示文摘 | Busca G Lietti L Ramis G | 1998 | Applied Catalysis B:Environmental1998，18，12： | 1 |
| 15 | Spatial resolution of phospholipid scramblase 1 (PLSCR1), caspase-3 activation and DNA-fragmentation in the human hippocampus after cerebral ischemia显示文摘 | Rami A Sims J Botez G | 2003 | Neurochem Int2003，43，： | 1 |
| 16 | Spatial resolution of phospholipid scramblase 1(PLSCR1),caspase-3 activation and DNA-frngmentation in the human hippocampus after cerebral ischemia显示文摘 | Rami A Sims J Botez G etal | 2003 | Neurochem Int2003，43，1： | 1 |
| 17 | Chemical and mechanistic aspects of the selective catalytic reduction of NOx by ammonia over oxide catalysts显示文摘 | Busca G Lietti L Ramis G | 1998 | Applied CatalysisB: Environmental1998，18，12： | 1 |
| 18 | Reactivity of V2O5-WO3/TiO2 catalysts in the selective catalytic reduction of nitric oxide by ammonia显示文摘 | LIETTI L ALEMANY J L FORZATTI P BUSCA G RAMIS G GIAMELLO E BREGANI F | 1996 | Catal Today1996，29，14： | 1 |
| 19 | FT-IR study of the adsorption and coadsorption of NO, NO2 and NH3 on TiO2 anatase 显示文摘 | Ramis G Busca G Lorenzelli V Forzatti P | 1990 | Applied Catalysis1990，64，： | 1 |
| 20 | Reli- ability estimation of structures under stochastic load- ing A case study on nuclear piping 显示文摘 | Hari Prasad M Rami Reddy G Dubey P N | 2013 | Nuclear Engineering and Design2013，254，702： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员